Justin P. Rubio

Griffith University — Australia

Medicine · Health Sciences

36h-index8.5kcitations93works10.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Sclerosis Research Studies(15), T-cell and B-cell Immunology(14), Gene expression and cancer classification(9), Malaria Research and Control(7), Pain Management and Opioid Use(7)

Publications90 total

Rare variation in neurological disease genes and its role in multiple sclerosis mimicry and phenotype
Genome Medicine·2025· 1 citedOpen Access
Integrating three-dimensional printing and bioprinting technologies to develop a stretchable in vitro model of the human airway
Bio-Design and Manufacturing·2025Open Access
The biomolecular profiles of extracellular vesicles from odontogenic stem cell lines depict donor-dependent differences and emphasize their therapeutic and regenerative potential
2025Open Access
Neuronal somatic mutations are increased in multiple sclerosis lesions
Nature Neuroscience·2025· 2 cited
Do CYP2D6 genotypes affect oxycodone dose, pharmacokinetics, pain, and adverse effects in cancer?
Pharmacogenomics·2024Open Access
Sophisticated human airway in vitro models to investigate cell-cell interactions in acute and chronic diseases
2024
Influence of <i>COMT</i> (rs4680) and <i>OPRM1</i> (rs1799971) on Cancer Pain, Opioid Dose, and Adverse Effects
Journal of Palliative Medicine·2024· 1 cited
Background and Breakthrough Opioid Choice May Determine Different Pain Outcomes
Journal of Pain and Symptom Management·2023Open Access
Opioid Switch Dosing in Chronic Cancer Pain: A Prospective Longitudinal Study
Journal of Palliative Medicine·2023· 2 cited
Effectiveness of Opioid Switching in Advanced Cancer Pain: A Prospective Observational Cohort Study
Cancers·2023· 5 citedOpen Access
Locus for severity implicates CNS resilience in progression of multiple sclerosis
Nature·2023· 203 citedOpen Access
Data from Saliva-Derived DNA Performs Well in Large-Scale, High-Density Single-Nucleotide Polymorphism Microarray Studies
2023Open Access
Supplementary Figures 1-5, Supplementary Tables 1-3, Full List of Authors and Affiliations from Saliva-Derived DNA Performs Well in Large-Scale, High-Density Single-Nucleotide Polymorphism Microarray Studies
2023Open Access
Supplementary Figures 1-5, Supplementary Tables 1-3, Full List of Authors and Affiliations from Saliva-Derived DNA Performs Well in Large-Scale, High-Density Single-Nucleotide Polymorphism Microarray Studies
2023Open Access
Data from Saliva-Derived DNA Performs Well in Large-Scale, High-Density Single-Nucleotide Polymorphism Microarray Studies
2023Open Access
Establishing a Longitudinal Opioid Pharmacogenomic Registry for Cancer Patients: Feasibility and Acceptability
Journal of Palliative Medicine·2022· 6 cited
The Role of Pharmacogenomics in Opioid Prescribing
Current Treatment Options in Oncology·2022· 36 citedOpen Access
The mutational landscape of single neurons and oligodendrocytes reveals evidence of inflammation-associated DNA damage in multiple sclerosis
2022· 2 citedOpen Access
Transcriptomic effects of rs4845604, an IBD and allergy-associated RORC variant, in stimulated ex vivo CD4+ T cells
PLoS ONE·2021Open Access
Using single cell DNA-seq to decipher disease mechanisms for MS
Multiple Sclerosis Journal·2020
page 1 of 5Next →

Frequent Co-authors

Trevor J. Kilpatrick(20), Helmut Butzkueven(15), Simon J. Foote(15), Jim Stankovich(15), Bruce Taylor(14), Melanie Bahlo(13), David R. Booth(8), Graeme J. Stewart(7), Laura Johnson(7), Robert Heard(7), Terence P. Speed(7), Judith Field(6), Anthony P. Monaco(6), Alan F. Cowman(6), Ingrid van der Mei(5), Matthew A. Brown(4), Patrick Danoy(4), Cathy Jensen(4), Adrian Danek(4), Alessandro Malandrini(4)